Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance (Q42990051)

12 November 2017

1 reference

title

Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance (English)

1 reference

12 November 2017

1 reference

1 reference

1

1 reference

12 November 2017

Korth MJ

2

1 reference

PubMed ID

9741641

12 November 2017

Katze MG

series ordinal

3

1 reference

PubMed ID

9741641

12 November 2017

language of work or name

1 reference

1 July 1998

1 reference

Clinical and diagnostic virology

12 November 2017

1 reference

12 November 2017

10

1 reference

12 November 2017

157-162

1 reference

12 November 2017

2-3

1 reference

Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

Molecular mechanisms responsible for malignant transformation by regulatory and catalytic domain variants of the interferon-induced enzyme RNA-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

Hepatitis C and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

The double-stranded RNA-dependent protein kinase PKR: structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

Therapy of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

Interaction of the interferon-induced PKR protein kinase with inhibitory proteins P58IPK and vaccinia virus K3L is mediated by unique domains: implications for kinase regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

The protein kinase family: conserved features and deduced phylogeny of the catalytic domains

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

Regulation of the interferon-induced PKR: can viruses cope?

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

Regulation of the protein kinase PKR by the vaccinia virus pseudosubstrate inhibitor K3L is dependent on residues conserved between the K3L protein and the PKR substrate eIF2alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

Genotypic analysis of hepatitis C virus in American patients

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

The interferon-inducible double-stranded RNA-activated protein kinase self-associates in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

PKR: a new name and new roles.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

Structural requirements for double-stranded RNA binding, dimerization, and activation of the human eIF-2 alpha kinase DAI in Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

The 58-kDa cellular inhibitor of the double stranded RNA-dependent protein kinase requires the tetratricopeptide repeat 6 and DnaJ motifs to stimulate protein synthesis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

A template for the protein kinase family

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0197%2898%2900034-8

7 January 2021

10.1016/S0928-0197(98)00034-8

Identifiers

DOI

1 reference

12 November 2017

1 reference

PubMed ID

9741641